Exercise News and Research

Latest Exercise News and Research

Santarus extends line of credit agreement maturation date to July 2013

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has extended the maturity date of its $25 million revolving line of credit with Comerica Bank from July 11, 2011 to July 11, 2013.

30 Aug 2010

MEND 7-13 Program improves obesity management in children

The MEND 7-13 Program today announced statistically significant results from 2009/2010 US Community Implementation Data. This preliminary data is the first to come from a US population and is further evidence that programs achieve positive outcomes and are welcomed by communities.

30 Aug 2010

Scientist suggests guidelines to safeguard physical health in college

College can be some of the best years of a person's life. But it is also a critical time, a time when students need to be aware of their health and safety. For women, many on their own for the first time in their lives, developing the ability to safeguard their emotional and physical health is paramount.

30 Aug 2010

Asia-Pacific convention on osteoporosis management

Clinicians, researchers and allied health professionals with an interest in osteoporosis and its prevention, diagnosis and management, are invited to convene in Singapore for the IOF Regionals - 1st Asia-Pacific Osteoporosis Meeting from December 10-13, 2010.

30 Aug 2010

Victhom second-quarter revenues decrease 94.4% to $27,901

Victhom Human Bionics Inc. today reported its second quarter 2010 financial results.

27 Aug 2010

Traumatic brain injury causes $6.8 billion worth of economic trauma in Texas

Each year in Texas, traumatic brain injury (TBI) causes an estimated $6.8 billion worth of economic trauma in terms of deaths, emergency room visits, hospitalizations and disability, according to a study commissioned by the CORE Health Foundation. To put that dollar amount in perspective, it equals Coca-Cola's corporate profit for fiscal 2009.

27 Aug 2010

Orexigen Therapeutics board approves grant of inducement stock options

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on August 25, 2010 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 10,000 shares of common stock to two new employees.

27 Aug 2010

FDA approves Novartis' Tekamlo for treatment of high blood pressure

The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.

27 Aug 2010

Smoking among youth declines, but much more needs to be done

The 2009 National Youth Tobacco Survey released today by the Centers for Disease Control and Prevention provides further evidence that the United States has made dramatic progress in reducing youth smoking, but the rate of decline has slowed significantly in recent years.

27 Aug 2010

Women who breastfeed are at lower risk of developing type 2 diabetes

Mothers who did not breastfeed their children have significantly higher rates of type 2 diabetes later in life than moms who breastfed, report University of Pittsburgh researchers in a study published in the September issue of the American Journal of Medicine.

27 Aug 2010

Study finds moderate exercise enhances DMN connectivity in specific regions of brain

A group of "professional couch potatoes," as one researcher described them, has proven that even moderate exercise - in this case walking at one's own pace for 40 minutes three times a week - can enhance the connectivity of important brain circuits, combat declines in brain function associated with aging and increase performance on cognitive tasks.

27 Aug 2010

Dietary supplement to boost nitric oxide increases stamina during high intensity exercise: Research

Research from the University of Exeter has revealed taking a dietary supplement to boost nitric oxide in the body can significantly boost stamina during high-intensity exercise.

27 Aug 2010

Cooper Institute receives contract from Texas Department to develop NUTRIGRAM for children

In an effort to curb the alarming rates of obesity in Texas, The Cooper Institute was recently awarded a contract from the Texas Department of Agriculture (TDA) to develop a nutrition assessment and educational service for students called NUTRIGRAM.

27 Aug 2010

New vibration technology to reduce stubborn stomach fat

For millions of dieters it seems impossible to lose belly fat no matter however carefully they watch what they eat or how many sit-ups they do. Some people give up and blame it on genetics, metabolism or body type and simply accept it as a fact of life. For whatever the reason, many Americans discover that stubborn fat around the stomach and love handles will not melt away despite their best efforts. Now a fitness research company says there is an effective way to win the battle of the bulge without special diets, drinks or difficult exercises.

27 Aug 2010

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.

26 Aug 2010

Affordable Care Act that mandates free preventative services goes into effect in September

Starting in September, President Obama's Affordable Care Act will go into effect. The act mandates free preventative services such as cholesterol or breast cancer screenings and tetanus shots. But the question is, will doctors and patients take advantage of these new preventative services? "Unfortunately, thanks to our American healthcare system, we have been programmed to focus on treatment and not prevention," said Dr. David Samadi, a urologic oncologist specializing in prostate cancer treatment and robotic surgery, who is also the Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City.

26 Aug 2010

Emisphere Technologies to raise $6.5 million from two private placement deals

Emisphere Technologies, Inc. today announced that on August 25, 2010, Emisphere Technologies, Inc. entered into a securities purchase agreement with certain institutional investors pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28.

26 Aug 2010

Nabi receives US patent for treatment and prevention of nicotine addiction with NicVAX conjugate vaccines

Nabi Biopharmaceuticals announced the receipt of a patent for treating and preventing nicotine addiction with NicVAX® and related nicotine conjugate vaccines. The United States Patent and Trademark office issued U.S. Patent No. 7,776,620 entitled "Hapten-carrier conjugates for treating and preventing nicotine addiction" for the exclusive use of methods for treating and preventing nicotine addiction with NicVAX and related nicotine vaccines. This patent runs through December 2018.

26 Aug 2010

FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy

Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.

26 Aug 2010

Angeion Corporation 2010 third quarter revenue increases to $7.1 million

Angeion Corporation today reported results for its fiscal third quarter ended July 31, 2010.

26 Aug 2010

Exercise News and Research

Latest Exercise News and Research

Santarus extends line of credit agreement maturation date to July 2013

MEND 7-13 Program improves obesity management in children

Scientist suggests guidelines to safeguard physical health in college

Asia-Pacific convention on osteoporosis management

Victhom second-quarter revenues decrease 94.4% to $27,901

Traumatic brain injury causes $6.8 billion worth of economic trauma in Texas

Orexigen Therapeutics board approves grant of inducement stock options

FDA approves Novartis' Tekamlo for treatment of high blood pressure

Smoking among youth declines, but much more needs to be done

Women who breastfeed are at lower risk of developing type 2 diabetes

Study finds moderate exercise enhances DMN connectivity in specific regions of brain

Dietary supplement to boost nitric oxide increases stamina during high intensity exercise: Research

Cooper Institute receives contract from Texas Department to develop NUTRIGRAM for children

New vibration technology to reduce stubborn stomach fat

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Affordable Care Act that mandates free preventative services goes into effect in September

Emisphere Technologies to raise $6.5 million from two private placement deals

Nabi receives US patent for treatment and prevention of nicotine addiction with NicVAX conjugate vaccines

FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy

Angeion Corporation 2010 third quarter revenue increases to $7.1 million

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Exercise News and Research

Latest Exercise News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in